[1] Teng M L, Ng C H, Huang D Q, et al. Global incidence and prevalence of nonalcoholic fatty liver disease[J]. Clin Mol Hepatol, 2023, 29(Suppl):S32-S42.
[2] Kaya E, Yilmaz Y. Metabolic-associated fatty liver disease (MAFLD):a multi-systemic disease beyond the liver[J]. J Clin Transl Hepatol, 2022, 10(2):329-338.
[3] European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)[J]. J Hepatol, 2024, 81(3):492-542.
[4] Younossi Z M, Zelber-Sagi S, Lazarus J V, et al. Global consensus recommendations for metabolic dysfunction-associated steatotic liver disease and steatohepatitis[J]. Gastroenterology, 2025, 169(5):1017-1032.
[5] 中华医学会肝病学分会. 代谢相关(非酒精性)脂肪性肝病防治指南(2024年版)[J]. 中华肝脏病杂志, 2024, 32(5):418-434.
[6] 管炬博, 范建高. 非酒精性脂肪性肝病患者心血管疾病风险的研究进展[J]. 肝脏, 2023, 28(8):892-894.
[7] Stefan N, Yki-Järvinen H, Neuschwander-Tetri B A. Metabolic dysfunction-associated steatotic liver disease:heterogeneous pathomechanisms and effectiveness of metabolism-based treatment[J]. Lancet Diabetes Endocrinol, 2025, 13(2):134-148.
[8] 中华中医药学会脾胃病分会. 肝癖中医诊疗专家共识(2023)[J]. 中国中西医结合消化杂志, 2024, 32(9):741-747.
[9] 中华中医药学会脾胃病分会. 非酒精性脂肪性肝病中医诊疗专家共识(2023)[J]. 中国中西医结合消化杂志, 2024, 32(1):1-7.
[10] 黄娜菲, 崔艺馨, 冯晓峰, 等. 基于文献挖掘的酒精性肝病中医证候要素及辨证规律研究[J]. 中西医结合肝病杂志, 2025, 35(3):283-289.
[11] Li H, Wang D. Acupuncture, a promising therapy for insulin resistance and non-alcoholic fatty liver disease[J]. Int J Gen Med, 2024, 17:4917-4928.
[12] 张海明. 电针通过SIRT1/NLRP3信号通路抑制细胞焦亡改善非酒精性脂肪性肝病的机制研究[D]. 武汉:湖北中医药大学,2023.
[13] Liu C, Ao Y, Liu B, Huang J, et al. The safety and efficacy of acupuncture in treating nonalcoholic fatty liver disease:a systematic review and meta-analysis based on randomized controlled trials[J]. Medicine (Baltimore), 2025, 104(18):e42272.
[14] Zhao J, Wang Q, Zhao X, et al. Electro-acupuncture reduced steatosis on MRI-PDFF in patients with non-alcoholic steatohepatitis:a randomized controlled pilot clinical trial[J]. Chin Med, 2023, 18(1):19.
[15] Zhou X L, Tang N, Wu T, et al. Mechanism of catgut embedding at back-shu points for nonalcoholic steatohepatitis based on IKK/IKB/NF-κB signaling pathway[J]. Zhongguo Zhen Jiu, 2020, 40(1):59-66.
[16] 叶苗青, 唐颖慧, 刘皎皎, 等. 穴位埋线配合中药治疗非酒精性单纯性脂肪肝的疗效观察[J]. 上海针灸杂志, 2024, 43(9):993-998.
[17] 周峰峰, 陈羽, 蔡浩亮, 等. 穴位埋线治疗非酒精性脂肪性肝病的临床疗效观察[J]. 上海中医药大学学报, 2024, 38(3):45-49.
[18] 陆英俊, 黄彬, 张红星. 穴位埋线治疗非酒精性脂肪肝疗效的Meta分析[J]. 广西中医药, 2021, 44(4):36-43.
[19] 乔正中. 耳穴诊治的理论基础是经络学说[J]. 中国针灸, 2002, 22(S1):211-212.
[20] 刘敬萱, 王锐卿, 张子迪, 等. 中国耳针不同流派比较与分析[J]. 中国针灸, 2020, 40(12):1363-1368.
[21] Pavlov V A, Tracey K J. Neural regulation of immunity:molecular mechanisms and clinical translation[J]. Nat Neurosci, 2017, 20(2):156-166.
[22] Guo K, Lu Y, Wang X, et al. Multi-level exploration of auricular acupuncture:from traditional Chinese medicine theory to modern medical application[J]. Front Neurosci, 2024, 18:1426618.
[23] 叶金连, 吴炳煌, 黄国芳. 体针联合耳穴压贴法治疗非酒精性脂肪性肝病30例临床观察[J]. 湖南中医杂志, 2020, 36(12):51-53.
[24] 郑珏. 推拿拍打操联合耳穴贴压干预轻度非酒精性脂肪肝(湿浊内停证)患者的临床疗效观察[J]. 贵州医药, 2022, 46(3):372-373.
[25] 黄晓彦, 成伯宁, 杨晓春, 等. 耳穴压豆加推拿拍打操对肥胖脂肪肝患者体格指标、血脂及肝功能的影响[J]. 中国基层医药, 2025, 32(5):735-741.
[26] 杨诗师. 糖肝煎丸联合经穴推拿改善肝郁脾虚型2型糖尿病合并肥胖患者糖脂代谢指标的临床研究[D]. 武汉:湖北中医药大学, 2024.
[27] 徐婧. 脏腑推拿联合生活方式干预对代谢综合征(痰浊瘀阻)患者体脂率影响的研究[D]. 长春:长春中医药大学, 2023.
[28] 陈丽丽, 丛德毓, 楚云杰, 等. 从“一气周流”探讨腹部推拿在脾虚痰湿型2型糖尿病合并肥胖治疗中的应用[J]. 山东中医杂志, 2023, 42(11):1203-1206.
[29] Han Y, Lu Z, Chen S, et al. Abdominal massage alleviates skeletal muscle insulin resistance by regulating the AMPK/SIRT1/PGC-1α signaling pathway[J]. Cell Biochem Biophys, 2021, 79(4):895-903.
[30] 管其凡. “运腹通经”推拿法联合调肝通络方治疗非酒精性脂肪肝的临床研究[D]. 长春:长春中医药大学, 2024.
[31] 刘金鑫. 腹部温通疗法治疗痰浊内阻型非酒精性脂肪性肝病的临床观察[D]. 武汉:湖北中医药大学, 2023.
[32] Wang G, Ju H, Zhang Z, et al. Comparative effectiveness of massage combined with lifestyle intervention and lifestyle intervention alone for simple obesity:a systematic review and meta-analysis[J]. Medicine (Baltimore), 2025, 104(2):e41074.
[33] Lin Y, Zeng H, Lin J, et al. Evaluating the therapeutic potential of moxibustion on polycystic ovary syndrome:a rat model study on gut microbiota and metabolite interaction[J]. Front Cell Infect Microbiol, 2024, 14:1328741.
[34] 石含峰, 胡阳凤. 艾灸配合药物对代谢相关脂肪性肝病患者粪便SCFAs、SIgA及血清LPS的影响[J]. 上海针灸杂志, 2023, 42(3):232-237.
[35] 房雨晨, 沈楠, 宁敏, 等. 艾灸联合调肝方穴位贴敷治疗非酒精性脂肪性肝病疗效观察[J]. 现代中西医结合杂志, 2025, 34(4):501-504.
[36] 庹青华, 吴薇薇, 陈帆. 温和灸联合健康宣教干预对非酒精性脂肪肝患者遵医行为及糖脂代谢水平的影响观察[J]. 中医外治杂志, 2021, 30(3):11-13.
[37] 赖丰芳. 宫廷灸与中医膳食及中医情志联合护理干预对非酒精性脂肪肝患者影响[J]. 中国医药指南, 2023, 21(27):42-45.
[38] 贺煜竣, 何就杰, 范郁山, 等. 基于数据挖掘技术分析针灸治疗代谢相关脂肪性肝病的选穴规律[J]. 针刺研究, 2024, 49(4):424-433.
[39] 尤圣杰, 林筱萱, 张晓辉, 等. 基于数据挖掘技术分析非酒精性脂肪性肝病中医外治法的选穴规律[J]. 中西医结合肝病杂志, 2025, 35(8):992-996. |
